This brand name is authorized in Ecuador, Spain, Tunisia
The drug MENAVEN contains one active pharmaceutical ingredient (API):
|
1
Heparin
UNII ZZ45AB24CA - HEPARIN SODIUM
|
|
Heparin is an anticoagulant and acts by inhibiting thrombin and by potentiating the naturally occurring inhibitors of activated Factor X (Xa). |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C05BA03 | Heparin | C Cardiovascular system → C05 Vasoprotectives → C05B Antivaricose therapy → C05BA Heparins or heparinoids for topical use |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 25.816-07-04 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58678, 58679 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 1273011 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
